1 terminated, 1 withdrawn. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Fluorine F 18 Ara-G: new trials by email Literature Review of Fluorine F 18 Ara-G trials Research Report on Fluorine F 18 Ara-G
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy Fluorine F 18 Ara-G - Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | Early Phase 1 | Withdrawn | University of California, Davis | 2019-11-05 | 2022-02-01 | |
| Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 Fluorine F 18 Ara-G, Positron Emission Tomography, Magnetic Resonance Imaging - Bladder Cancer | Phase 2 | Terminated | Lawrence Fong | 4 | 2017-03-07 | 2020-01-21 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Urinary Bladder Neoplasms (1)
Lawrence Fong (1) · University of California, Davis (1)
United States (1)
Julie Sutcliffe (1) · Lawrence Fong, MD (1)
P30CA093373 (1)